164 related articles for article (PubMed ID: 31348233)
21. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
22. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
[TBL] [Abstract][Full Text] [Related]
23. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
[TBL] [Abstract][Full Text] [Related]
24. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract][Full Text] [Related]
25. Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer.
Sal V; Demirkiran F; Erenel H; Tokgozoglu N; Kahramanoglu I; Bese T; Turan H; Sofiyeva N; Calay Z; Arvas M; Guralp O
Int J Gynecol Cancer; 2016 Mar; 26(3):512-20. PubMed ID: 26894937
[TBL] [Abstract][Full Text] [Related]
26. Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
Trédan O; Treilleux I; Wang Q; Gane N; Pissaloux D; Bonnin N; Petit T; Cretin J; Bonichon-Lamichhane N; Priou F; Lavau-Denes S; Mari V; Freyer G; Lebrun D; Alexandre J; Ray-Coquard I
Target Oncol; 2013 Dec; 8(4):243-51. PubMed ID: 23238879
[TBL] [Abstract][Full Text] [Related]
27. MMAC/PTEN gene expression in endometrial cancer: RT-PCR studies.
Sobczuk A; Smolarz B; Romanowicz-Makowska H; Pertyński T
Pol J Pathol; 2006; 57(3):137-40. PubMed ID: 17219740
[TBL] [Abstract][Full Text] [Related]
28. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
29. Concomitant p53 and PTEN immunoexpression to predict the risk of malignancy in endometrial polyps.
Abrão F; Modotti WP; Spadoto-Dias D; Bueloni-Dias FN; Leite NJ; Peres GF; Elias LV; Domingues MAC; Dias R
Medicine (Baltimore); 2018 Sep; 97(38):e12304. PubMed ID: 30235677
[TBL] [Abstract][Full Text] [Related]
30. PTEN protein expression has role in predicting disease-free-interval in endometrioid endometrial carcinoma.
Shafiee MN; Lim WK; Poh Shwen Shi C; Mohamed Yasin IA; Azemi AF; Zakaria ML; Hannaan Abdul Hafizz AM; Mustangin M; Chandralega Kampan N; Abd Aziz NH; Md Zain RR
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):403-410. PubMed ID: 34364315
[TBL] [Abstract][Full Text] [Related]
31. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.
Guo C; Song WQ; Sun P; Jin L; Dai HY
J Biomed Sci; 2015 Oct; 22():100. PubMed ID: 26511107
[TBL] [Abstract][Full Text] [Related]
32. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
33. Role of exon 7 PTEN Gene in Endometrial Carcinoma.
Kafshdooz L; Kafshdooz T; Tabrizi AD; Mohaddes Ardabili SM; Akbarzadeh A; Gharesouran J; Ghojazadeh M; Farajnia S
Asian Pac J Cancer Prev; 2015; 16(11):4521-4. PubMed ID: 26107197
[TBL] [Abstract][Full Text] [Related]
34. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
Lacey JV; Mutter GL; Ronnett BM; Ioffe OB; Duggan MA; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer Res; 2008 Jul; 68(14):6014-20. PubMed ID: 18632658
[TBL] [Abstract][Full Text] [Related]
35. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
[TBL] [Abstract][Full Text] [Related]
36. Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas.
Akiyama-Abe A; Minaguchi T; Nakamura Y; Michikami H; Shikama A; Nakao S; Sakurai M; Ochi H; Onuki M; Matsumoto K; Satoh T; Oki A; Yoshikawa H
Br J Cancer; 2013 Sep; 109(6):1703-10. PubMed ID: 23949151
[TBL] [Abstract][Full Text] [Related]
37. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
38. PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
Westin SN; Ju Z; Broaddus RR; Krakstad C; Li J; Pal N; Lu KH; Coleman RL; Hennessy BT; Klempner SJ; Werner HM; Salvesen HB; Cantley LC; Mills GB; Myers AP
Mol Oncol; 2015 Oct; 9(8):1694-703. PubMed ID: 26045339
[TBL] [Abstract][Full Text] [Related]
39. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
40. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
